Press Release Archive
Press Releases
May 2024
05.06.2024
05.01.2024
April 2024
04.29.2024
Prescription Medicines Medicines FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
04.29.2024
04.26.2024
Prescription Medicines Medicines U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
04.25.2024
Corporate Finance Pfizer Announces 2024 Shareholder Meeting Preliminary Results
04.24.2024
Corporate Finance Pfizer Declares Second-Quarter 2024 Dividend
04.22.2024
04.11.2024
04.09.2024
March 2024
03.20.2024
03.13.2024
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.